Bulletin from Annual General Meeting: One of the most significant years in Diamyd’s history
At Diamyd Medical’s Annual General Meeting on December 9, Elisabeth Lindner, President and CEO of Diamyd, said that the past year was one of the most significant years in the history of the company and that the foundation has been laid upon which a new Swedish pharmaceutical company can be built.“I am very pleased that we continued to deliver according to plan in the past year,” says Elisabeth Lindner, President and CEO of Diamyd Medical. “Following an eventful year, we will now continue to develop Diamyd into a new Swedish pharmaceutical company.” In addition to the signing of a
